Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (41)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Murphy, T. F.
Right arrow Articles by Niederman, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Murphy, T. F.
Right arrow Articles by Niederman, M. S.
(Chest. 2000;118:204-209.)
© 2000 American College of Chest Physicians

The Role of Bacteria in Exacerbations of COPD*

A Constructive View

Timothy F. Murphy, MD; Sanjay Sethi, MD and Michael S. Niederman, MD, FCCP

* From the VA Western New York Healthcare System (Drs. Murphy and Sethi), Buffalo, NY; and Winthrop-University Hospital (Dr. Niederman), Mineola, NY.

Correspondence to: Michael S. Niederman, MD, FCCP, Pulmonary and Critical Care Medicine, Winthrop-University Hospital, 222 Station Plaza N, Suite 400, Mineola, NY 11501; e-mail: mniederman{at}winthrop.org

Abstract

The role of infection in exacerbations of COPD remains controversial and incompletely understood. Although some investigators believe that bacteria are not important for patients with exacerbation, we disagree and believe that patients with at least two of the three cardinal symptoms of exacerbation should receive antibiotic therapy. With an open-minded view of the area, we review the data, showing that bacteriologic studies, pathologic investigations, and clinical trials all support roles for bacteria and antibiotic therapy in this disease. Still, many questions remain, and future studies will be needed to better define the mechanisms of bacterial invasion in the bronchitic patient and to develop effective vaccines to prevent exacerbations. In the meantime, we must rely on antibiotic therapy, and we will need prospective studies to corroborate preliminary findings showing that different patients may require different therapies; thus, patient subsetting may be vital in the selection of antibiotic therapy for exacerbations of COPD.

Key Words: antibiotic therapy • bacterial bronchitis • chronic bronchitis • exacerbation • immune response • nontypeable H influenzae • vaccines




This article has been cited by other articles:


Home page
Proc Am Thorac SocHome page
D. C. Look, C. L. Chin, L. J. Manzel, E. E. Lehman, A. L. Humlicek, L. Shi, T. D. Starner, G. M. Denning, T. F. Murphy, and S. Sethi
Modulation of Airway Inflammation by Haemophilus influenzae Isolates Associated with Chronic Obstructive Pulmonary Disease Exacerbation
Proceedings of the ATS, August 1, 2006; 3(6): 482 - 483.
[Full Text] [PDF]


Home page
ThoraxHome page
R Wilson, P Jones, T Schaberg, P Arvis, I Duprat-Lomon, P P Sagnier, and for the MOSAIC Study Group
Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis
Thorax, April 1, 2006; 61(4): 337 - 342.
[Abstract] [Full Text] [PDF]


Home page
ERRHome page
R. Wilson
Treatment of COPD exacerbations: antibiotics
Eur. Respir. Rev., September 1, 2005; 14(94): 32 - 38.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
S. L. Johnston
Overview of Virus-induced Airway Disease
Proceedings of the ATS, August 1, 2005; 2(2): 150 - 156.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. L. Chin, L. J. Manzel, E. E. Lehman, A. L. Humlicek, L. Shi, T. D. Starner, G. M. Denning, T. F. Murphy, S. Sethi, and D. C. Look
Haemophilus influenzae from Patients with Chronic Obstructive Pulmonary Disease Exacerbation Induce More Inflammation than Colonizers
Am. J. Respir. Crit. Care Med., July 1, 2005; 172(1): 85 - 91.
[Abstract] [Full Text] [PDF]


Home page
Proc Am Thorac SocHome page
R. Buhl and S. G. Farmer
Current and Future Pharmacologic Therapy of Exacerbations in Chronic Obstructive Pulmonary Disease and Asthma
Proceedings of the ATS, April 1, 2004; 1(2): 136 - 142.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. S. Niederman
Does the Presence of Antibodies Justify the Use of Antibiotics in Exacerbations of Chronic Bronchitis?
Am. J. Respir. Crit. Care Med., February 15, 2004; 169(4): 434 - 435.
[Full Text] [PDF]


Home page
NEJMHome page
S. Sethi, N. Evans, B. J.B. Grant, and T. F. Murphy
New Strains of Bacteria and Exacerbations of Chronic Obstructive Pulmonary Disease
N. Engl. J. Med., August 15, 2002; 347(7): 465 - 471.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
M. S. Niederman, S. Sethi, and F. Martinez
Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Ann Intern Med, April 2, 2002; 136(7): 557 - 557.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
V. Snow
Acute Exacerbations of Chronic Obstructive Pulmonary Disease
Ann Intern Med, April 2, 2002; 136(7): 557 - 558.
[Full Text] [PDF]


Home page
ChestHome page
J. V. Hirschmann, T. F. Murphy, S. Sethi, and M. S. Niederman
Bacteria and COPD Exacerbations Redux
Chest, February 1, 2001; 119(2): 663 - 667.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American College of Chest Physicians.